Latest News in the pharma Industry

All

International Multidisciplinary Course on Iron Deficiency 2018: the results of the 6th edition

International Multidisciplinary Course on Iron Deficiency 2018: the results of the 6th edition

19 Jul 2018

On April 13th and 14th Lisbon was the scene of the sixth edition of the International Multidisciplinary Course on Iron Deficiency (IMCID), organized as every year by PharmaNutra SPA in collaboration with Zambon, the compan...

Read more 
New great success for Cetilar®:  PharmaNutra obtains the patent grant

New great success for Cetilar®: PharmaNutra obtains the patent grant

19 Jul 2018

A new, fundamental strategic business asset has been added to those already owned by PharmaNutra SPA. On 5 February 2018 the company received from the Italian Patent Office the patent grant for Cetilar ® RM (number 102015000044822).

Read more 
Sucrosomial ® Iron award-winning product of the year by Israeli consumers

Sucrosomial ® Iron award-winning product of the year by Israeli consumers

19 Jul 2018

The Sucrosomial ® technology, patent of the PharmaNutra Group at the base of the SiderAL® products, continues to gain important consents from the international markets. In fact Comfort Iron, a product launched at the beginning of 2017 exclusively ...

Read more 
SEA Vision expands global presence with €1.5 million investment

SEA Vision expands global presence with €1.5 million investment

18 Jul 2018

Growing demand for agile and local-based vendors in the US, Germany and Russia.

Read more 
New screening company exploits the latest advances in microfluidics and 3D culture

New screening company exploits the latest advances in microfluidics and 3D culture

19 Jul 2018

The ability to micro size drug-cell interactions will allow pharmaceutical and biotech companies to do 100x more testing for the same money spent as well as increasing productivity.

Read more 
ProBioGen and Pionyr initiate 2nd immuno-oncology contract development and manufacturing project

ProBioGen and Pionyr initiate 2nd immuno-oncology contract development and manufacturing project

18 Jul 2018

Parallel cell line development and analysis will allow for optimal cell line selection while compressing the development timeline.

Read more 
FDA approves first smallpox drug

FDA approves first smallpox drug

17 Jul 2018

Action ensures that the US is prepared should smallpox be used as a bioweapon.

Read more 
Nemera receives Drug Manufacturing Authorization (Drug handling) for its Neuenburg plant, in Germany

Nemera receives Drug Manufacturing Authorization (Drug handling) for its Neuenburg plant, in Germany

16 Jul 2018

Important achievement for Nemera, now able to handle, assemble, sterilize and store pharmaceutical drugs and medicinal products for Autoinjectors.

Read more 
South Korea's finished drug market growth driven by generics

South Korea's finished drug market growth driven by generics

16 Jul 2018

FDF launches at CPhI Korea as country set to become regional hub.

Read more 
Almac Group Invests in NMR Equipment to Enhance Existing Analytical Services Capability

Almac Group Invests in NMR Equipment to Enhance Existing Analytical Services Capability

16 Jul 2018

Craigavon, N.I., 16 July 2018 – Almac Group, the global contract development and manufacturing organisation, has announced a £375,000 investment in additional NMR instrumentation at its global Headquarters, Craigavon, UK.

Read more 
Wasdell Group launches serialisation service

Wasdell Group launches serialisation service

13 Jul 2018

Company will offer compliant products to all markets, including Europe and the US.

Read more 
IntelGenx receives CIPO notice of allowance for Loxapine VersaFilm™ patent

IntelGenx receives CIPO notice of allowance for Loxapine VersaFilm™ patent

13 Jul 2018

SAINT LAURENT, Quebec, July 05, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSXV:IGX) (OTCQX:IGXT) (“IntelGenx” or the “Company”), a leading oral drug delivery company primarily focused on the development and manufacturing of innovative pharmaceutical or...

Read more